Download User Guide

196 results returned.
Page   of  13

305 Ill. Comp. Stat. § 5/5-4.1. Co-payments: Medical Assistance – Illinois
Status: Enacted     Year Enacted: 1981
Co-payments are permissible for most health care services, but not for chronic illness treatment. There is a $2 co-pay for generic drugs.
Download
35 Pa. Stat. and Cons. Stat. Ann. §§ 960.1 through 960.7: Generic Equivalent Drug Law – Pennsylvania
Status: Enacted     Year Enacted: 1976
It is the purpose of this act to permit consumers to secure necessary drugs at the most economical cost consistent with the professional discretion of the purchaser’s physician and pharmacist.
Download
40 Pa. Stat. and Pa. Cons. Stat. §§ 4501 through 4503, 4531 through 4535, 4551 through 4562: Pharmacy Audit Integrity and Transparency Act – Pennsylvania
Status: Enacted     Year Enacted: 2016
Governs PBM cost transparency requirements.
Download
A 00612 (see companion bill S 02391) – New York
Introduced: 2019    Status: Inactive / Dead    
Requires the commissioner of health to establish and publish a list of generic drug products.

A 01924 – New York
Introduced: 2019    Status: Inactive / Dead    
Authorizes a pharmacist to substitute a brand name prescription drug for the generic equivalent of such drug if requested to do so by the patient and record the request.

A 1396 (see companion bill S 3762) – New York
Introduced: 2021    Status: Enacted    
Provides for pharmacy benefit management and the procurement of prescription drugs to be dispensed to patients, or the administration or management of prescription drug benefits; sets forth definitions; provides for funds received by a pharmacy …

A 1923 (see companion bill S 5158) – New York
Introduced: 2021    Status: In Process    
Requires the commissioner of health to establish and publish a list of generic drug products.

A 236 (see companion bill S 5471) – New York
Introduced: 2017    Status: Inactive / Dead    
REQUIRES THE COMMISSIONER OF HEALTH TO ESTABLISH AND PUBLISH A LIST OF GENERIC DRUG PRODUCTS: The commissioner shall establish and publish a list of drug products matched to brand name drugs with which they have …

A 3987 (see companion bill S 1590) – New Jersey
Introduced: 2018    Status: Inactive / Dead    
PROHIBITS EXCESSIVE INCREASES IN PRICES CHARGED FOR ESSENTIAL OFF-PATIENT AND GENERIC PRESCRIPTION DRUGS AND BIOLOGICAL PRODUCTS: manufacturers and wholesale distributors may not engage in price gouging in the sale of an essential off-patent or generic …

A 5289 – New York
Introduced: 2021    Status: In Process    
Authorizes a pharmacist to substitute a brand name prescription drug for the generic equivalent of such drug if requested to do so by the patient and record the request.

A 7196 (see companion bill S 5169) – New York
Introduced: 2019    Status: Inactive / Dead    
Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of agreements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.

A 7245 (see companion bill S 4370) – New York
Introduced: 2021    Status: In Process    
Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, is to …

A 7509 (see companion bill S 4788A) – New York
Introduced: 2018    Status: Enacted    
INTERCHANGEABLE BIOLOGICAL PRODUCTS: Allows a pharmacist to dispense a lower cost generically equivalent drug product or interchangeable biological product.

A 8824 (see companion bill S 398) – New York
Introduced: 2022    Status: In Process    
Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.

A 8838 (see companion bill S 7837) – New York
Introduced: 2022    Status: In Process    
Provides for pharmacy benefit management and the procurement of prescription drugs to be dispensed to patients, or the administration or management of prescription drug benefits; sets forth definitions; provides for funds received by a pharmacy …

AB 1046 (see companion bill SB 874) – Wisconsin
Introduced: 2018    Status: Inactive / Dead    
This bills requires that no manufacturer or wholesale distributor may sell or offer to sell an essential off-patent or generic drug at a price that results in price gouging. Under the bill, price gouging means …

196 results returned.
Page   of  13

© 2018-2020 The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.